Efficacy Of New Temperature-controlled Radiofrequency Technology On Stress Urinary Incontinence

Objective: To study the clinical effect of new temperature-controlled radiofrequency technology in the treatment of stress urinary incontinence,and to provide a new treatment method for stress urinary incontinence.Methods: The clinical data of 48 patients with stress urinary incontinence(SUI)aged 30-65 years who were treated at the First Affiliated Hospital of Xinjiang Medical University in Urumqi from March 2021 to June 2022 were collected and treated with new temperature controlled radio frequency technology.New temperature-controlled radiofrequency technology was given once every two weeks,Each patient underwent 10 vulvar treatments.According to the amount of urine leakage before treatment,the patients were divided into three groups: mild,moderate,and severe.Urinary leakage before and after treatment was observed and analyzed,which mainly included:(1)General information of patients before treatment: age,BMI,reproductive history,menstrual history,SUI course(2)Urinary leakage: a 1-hour urine pad experiment,a Three days of urination diary(number of urine leakage per day,number of urination per day,and average urination volume),and the International Counseling Questionnaire for Urinary Incontinence(ICI-Q-SF).Observation and comparison are mainly made through the following observation indicators: The 1-hour urine pad test and ICI-Q-SF table were recorded for 10 comparisons and 3 months after the end of treatment.Abnormal urination in a Three days of urination diary with a three-month follow-up after the end of 10 vulvar treatments was recorded.The difference of urine leakage before and after treatment in mild,moderate and severe SUI patients was compared.Results:(1)Comparison of general cases: There were significant differences among the three groups of data in terms of BMI,delivery times,maximum birth weight,course of SUI,and menopause(P<0.05).After pairwise comparison,there was no significant difference between mild and moderate SUI patients in terms of BMI,delivery times,maximum birth weight,course of SUI,and menopause(P>0.05).There was no significant difference between moderate and severe SUI patients in terms of delivery times and menopause(P>0.05).There were no significant differences in the number of pregnancies,age,education level and delivery mode of SUI patients in mild,moderate and severe groups(P > 0.05).(2)The amount of urine leakage from the 1-hour urine pad test in patients in the mild and moderate groups was lower than before treatment and after 10 treatments(P<0.05),while the amount of urine leakage from the 1-hour urine pad test in patients in the severe group was lower than before treatment(P<0.05),but there was no significant difference compared to 10 treatments later(P>0.05).It is used to compare the difference of 1-hour urinary pad test between SUI patients in the light,medium,and severe groups before treatment and 3 month after the end of treatment.The difference of 1-hour urinary pad test among the three groups was statistically significant(P<0.05);After comparison,there was statistical significance(P<0.05).There was a statistically significant difference in the ICI-Q-SF scores of patients in the mild and moderate groups before and after treatment(P<0.05),while there was no statistically significant difference in the ICI-Q-SF scores of patients in the severe group before and after treatment(P>0.05).After treatment,the average single urination volume of SUI patients was higher than before treatment(P<0.05),and the number of urination and urine leakage was lower than before treatment(P<0.05).(3)Observation of safety indicators: the subjects did not experience severe vaginal scalding,scarring,severe infection,palpitation,shortness of breath and other discomforts during the treatment.Conclusions: The new temperature-controlled radio frequency technology has a good effect on mild and moderate SUI,which is conducive to improving urine leakage and improving the quality of life of patients,and can improve the clinical symptoms of patients with severe SUI,but the efficacy is worse than that of patients with mild and moderate SUI.